Integrative Radiogenomics Approach for Risk Assessment of Postoperative and Adjuvant Chemotherapy Benefits for Gastric Cancer Patients
Gastric cancer (GC) is a typical heterogeneous malignant tumor, whose insensitivity to chemotherapy is a common cause of tumor recurrence and metastasis. There is no doubt regarding the effectiveness of adjuvant chemotherapy (ACT) for GC, but the population for whom it is indicated and the selection...
Guardado en:
Autores principales: | Yin Jin, Yilun Xu, Yanyan Li, Renpin Chen, Weiyang Cai |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/20aa359a29484ab28165cbedfe051ff0 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Correlative Analysis Between Adverse Events of Preoperative Chemotherapy and Postoperative Complications of Gastric Cancer
por: Zhouqiao Wu, et al.
Publicado: (2021) -
Effect of long-term adjuvant temozolomide chemotherapy on primary glioblastoma patient survival
por: Bin Huang, et al.
Publicado: (2021) -
Evaluation of anemia as a postoperative risk factor in the evolution of patients with gastric resection for malignancies
por: Bogdan Dumitriu, et al.
Publicado: (2021) -
Time to Adjuvant Chemotherapy and Its Predictors Among Women with Breast Cancer at the University of Gondar Compressive Specialized Hospital: A Retrospective Follow-Up Study
por: Zeleke Alem A, et al.
Publicado: (2020) -
Radiogenomics: Hunting Down Liver Metastasis in Colorectal Cancer Patients
por: Carolina de la Pinta, et al.
Publicado: (2021)